AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Counts, G. W.
Right arrow Articles by Turck, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Counts, G. W.
Right arrow Articles by Turck, M.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1977 April; 11(4): 708-711
Copyright © 1977 American Society for Microbiology. All Rights Reserved.

Cefazaflur, a New Parenteral Cephalosporin: In Vitro Studies

George W. Counts, David Gregory, Dolores Zeleznik and Marvin Turck

1 Department of Medicine, University of Washington and Harborview Medical Center, Seattle, Washington 98104

ABSTRACT

Cefazaflur was tested in vitro against 262 strains of bacteria. Inhibitory and bactericidal concentrations were determined with two inoculum sizes of bacterial cells in Mueller-Hinton broth and nutrient broth. Agar dilution studies also were performed. When tested in agar, 5.0 µg or less of cefazaflur per ml inhibited almost all strains of Staphylococcus aureus, Escherichia coli, Klebsiella, and Proteus mirabilis. The drug was less active against Enterobacter and indole-positive Proteus, and 7.5 µg of antibiotic per ml inhibited approximately two-thirds to one-fourth of the strains. A concentration of 50 µg of cefazaflur per ml was required for inhibition of the enterococci. There was negligible activity against Pseudomonas. The drug demonstrated less activity in broth than in agar, and a major inoculum effect was seen with some strains. For example, with a lower inoculum, 2.5 µg of cefazaflur per ml killed all strains of E. coli, whereas with the higher inoculum, 7.5 µg of cefazaflur per ml, inhibited 64% and killed only 8% of strains. The activity of the drug for some strains was greater in Mueller-Hinton broth; for others, it was greater in nutrient broth. There were considerable differences in the results of the broth and agar studies for some species when the same medium was employed. Because of differences in activity found with different media, inocula, and method of testing, an evaluation of the eventual usefulness of cefazaflur must await the results of in vivo studies.


Antimicrob Agents Chemother. 1977 April; 11(4): 708-711
Copyright © 1977 American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1977 by the American Society for Microbiology. All rights reserved.